Androgenetic alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: 2.5 mg minoxidil tablets, once daily and gradually increasing the dose to twice daily for six months orally. Intervention 2: Control group: 5% minoxidil solution on
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age above 18 years AGA patients based on clinical examination and trichoscopy Male gender Patients with grade3 to 5 according to Hamilton's classification for male pattern hair loss
Exclusion criteria
Exclusion criteria: Another treatments for hair loss in the last 3 months Alcohol and drug use High blood pressure Heart disease Allergy to study drugs Severe liver and kidney diseases Simultaneous use of other AGA treatments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total hair density, hair thickness,and the total number of vellus and terminal hairs. Timepoint: before the start of the study and 1, 2, 3 ,6 months after the start of the study. Method of measurement: Using digital video trichoscope and photography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Total hair density per centimeter square, hair thickness, number of hairs per follicular unit and patient's quality of life based on DLQI. Timepoint: 1, 2, 3 ,6 months after the initiation of the study. Method of measurement: Using a digital video trichoscope. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham yousefi
Tehran University of Medical Sciences
Outcome results
None listed